Overview

Antimicrobial Susceptibility Testing Market is predicted to value over USD 4.6 billion by 2027 end with a CAGR of over 5.4% during the forecast period 2020 to 2027.

Increased occurrence of infectious diseases worldwide, the initiation of antimicrobial resistance owing to drug overuse, rising initiatives by the government for controlling and detecting species with antimicrobial resistance are some of the major driving factors contributing to the antimicrobial susceptibility testing market growth. There has been a rising insistence for clinical microbiology testing procedures over the last few years leading to a steady proliferation of the market. Furthermore, with the rising prevalence of infectious diseases, the insistence for clinical microbiology processes for antimicrobial susceptibility and microbial identification testing for pathogens is predicted to experience substantial growth throughout the forecasted timeframe. With an extensive information available over bacterial pathogens and their susceptibility towards antimicrobials, it shall help in adopting appropriate therapies which is important for managing diseases.

According to multiple reports published by WHO, over 28,000 Ebola virus cases were reported in March 2016 and the countries affected by this virus were the United States, Italy, Spain, Nigeria, Senegal, Liberia, Mali, Sierra Leone and Guinea. Furthermore, over 10 million people were predicted to be diagnosed with tuberculosis in 2016 and over 1.6 million people died owing to tuberculosis. Similarly, in 2015, over 210 million were affected by malaria with over 85% deaths recorded in Africa. Such statistics states the growing prevalence of epidemics across the world, thereby increasing the antimicrobial susceptibility testing market demand.

The medical reimbursements for microbial testing are scarcely available is one of the primary factors impeding the market growth. Moreover, the emergence of expensive antimicrobial products has severely affected the growth of the market, especially in the United States. The healthcare services coding provides the medical reimbursements in the Unites States and these are looked after by the American Medical Association combined with the International Classification of Diseases codes. With such stringent regulations for reimbursements, the market growth is likely to be impeded during the forecast period.

Market Segmentation:

By Product

• Automated Laboratory Instruments
• Manual Antimicrobial Susceptibility Testing Products
o Susceptibility Testing Disks
o MIC Strips
o Susceptibility Plates
• Culture and Growth Media
• Consumables

By Method

Dilution
Disk Diffusion
ETEST
Automated Antimicrobial Susceptibility Testing
Genotypic Methods

By Type

Antibacterial Testing
Antifungal Testing
Antiparasitic Testing
Other Susceptibility Testing

By Application

Clinical Diagnostics
Drug Discovery and Development
Epidemiology
Other Applications

By End User

Diagnostic Centers and Hospitals
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Research and Academic Institutes

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The manual antimicrobial susceptibility segment is anticipated to lead the market owing to advantages like low cost, reduced cost of labour, ease of use. The disk diffusion segment is predicted to account the largest antimicrobial susceptibility testing market share owing to the economy and flexibility of these techniques. The antibacterial testing segment is estimated to dominate the market, and this is mainly due to a rising occurrence of infections owing to bacterial pathogens and rising stringencies with guidelines.

Regional Analysis:

The North America region is predicted to lead the market during the forecast period owing to ease of access and rising acceptance of advanced technologies pertaining to susceptibility testing products and methods. Furthermore, rising antimicrobial resistance in North America is another crucial factor contributing to the market growth in the region.

Competitive Landscape:

The key market players associated are bioMérieux , BD, Danaher, Thermo Fisher, Bio-Rad Laboratories, Hi-Media, MERLIN, Liofilchem, Accelerate, Alifax, Creative Diagnostics, Merck Group, Synbiosis, Bioanalyse, Zhuhai DL Biotech.

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global antimicrobial susceptibility testing market by product, by method, by type, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com